Study reveals lasting quality of life inequities in breast cancer patients

FHS
June 19, 2024
3:17 am

When it comes to health, inequalities can be seen at every level for women with breast cancer: prevention, screening, diagnosis, treatment, and survival.

FDA Rejects MDMA-Assisted Therapy for PTSD

The FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD), calling for another trial to evaluate the drug’s efficacy and safety, developer

August 10, 2024

The power of preference: How healthcare providers can build trust with consumers – Pharmaceutical Technology

Share this article Patients play their cards close to their chest when it comes to sharing their personal information. But despite hesitancy to spread their

January 16, 2024

FDA Warns of Overdoses With Compounded Semaglutide

Overdoses, some even requiring hospitalization, have occurred due to patient and physician confusion around compounded semaglutide, the FDA detailed in an alert. Adverse events reported

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.